EDWARD GRAVISS to Biomarkers
This is a "connection" page, showing publications EDWARD GRAVISS has written about Biomarkers.
Connection Strength
0.131
-
Pre-transplant T-cell Clonality: An Observational Study of a Biomarker for Prediction of Sepsis in Liver Transplant Recipients. Ann Surg. 2021 09 01; 274(3):411-418.
Score: 0.022
-
Kidney Transplant Recipients Rarely Show an Early Antibody Response Following the First COVID-19 Vaccine Administration. Transplantation. 2021 07 01; 105(7):e72-e73.
Score: 0.022
-
Alpha-Fetoprotein as a Modifier of Anatomic Criteria for Transplantation of HCC Patients. Transplant Proc. 2021 Apr; 53(3):833-838.
Score: 0.021
-
Relationship of extracellular volume assessed on cardiac magnetic resonance and serum cardiac troponins and natriuretic peptides with heart failure outcomes. Sci Rep. 2019 12 27; 9(1):20168.
Score: 0.020
-
Predictive value of serum bradykinin and desArg9-bradykinin levels for chemotherapeutic responses in active tuberculosis patients: A retrospective case series. Tuberculosis (Edinb). 2016 12; 101S:S109-S118.
Score: 0.016
-
Differentiating between live and dead Mycobacterium smegmatis using autofluorescence. Tuberculosis (Edinb). 2016 12; 101S:S119-S123.
Score: 0.016
-
Fluorogenic probes with substitutions at the 2 and 7 positions of cephalosporin are highly BlaC-specific for rapid Mycobacterium tuberculosis detection. Angew Chem Int Ed Engl. 2014 Aug 25; 53(35):9360-4.
Score: 0.014